METTL3 and gastric cancer: As shown in Figure 4, high METTL3 expression was found to be a negative prognostic factor in GC patients, with those who had higher METTL3 expression having a shorter OS time than those who had lower METTL3 expression (HR = 1.46, log-rank P < 0.01).